
Kiwi Biosciences
Patent-pending enzymes to break down common dietary triggers
About
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
Topics
- Location
- Boston, MA, United States
- Team size
- 10 employees
- YC batch
- Summer 2021
- Status
- Active
- Stage
- Early stage





